|
Euthyroid, n (%)
|
Subclinical hypothyroidism, n (%)
|
OR (CI 95%)
|
Overt hypothyroidism, n (%)
|
OR (CI 95%)
|
Overt + subclinical hypothyroidism, n (%)
|
OR (CI 95%)
|
Subclinical hyperthyroidism, n (%)
|
OR (CI 95%)
|
Overt hyperthyroidism, n (%)
|
OR (CI 95%)
|
Overt + subclinical hyperthyroidism, n (%)
|
OR (CI 95%)
|
---|
Sex
|
Men
|
281 (54.1)
|
27 (37.5)
|
1.96 (1.18–3.26)*
|
4 (44.4)
|
1.47 (0.39–5.55)
|
31 (38.3)
|
1.90 (1.17–3.07)*
|
2 (20)
|
4.7 (0.99–22.45)*
|
0 (0)
| |
2 (13.3)
|
7.67 (1.17–34.34)*
|
Women
|
238 (45.9)
|
45 (62.5)
|
5 (55.6)
|
50 (61.7)
|
8 (80)
|
5 (100)
|
13 (86.6)
|
Age (years)
|
20–40
|
153 (29.7)
|
14 (19.4)
|
1
|
4 (44.4)
|
1
|
18 (22.2)
|
1
|
4 (40)
|
1
|
2 (40)
|
1
|
6 (40)
|
1
|
40–60
|
274 (53.2)
|
42 (58.3)
|
1.67 (0.88–3.16)
|
2 (22.2)
|
0.27 (0.05–1.54)
|
44 (54.3)
|
1.36 (0.76–2.44)
|
5 (50)
|
0.69 (0.18–2.63)
|
2 (40)
|
0.55 (0.07–4.00)
|
7 (46.7)
|
0.65 (0.21–1.97)
|
≥60
|
88 (17.1)
|
16 (22.2)
|
1.98 (0.92–4.26)
|
3 (33.3)
|
1.3 (0.28–5.96)
|
19 (23.5)
|
1.83 (0.91–3.68)
|
1 (10)
|
0.43 (0.04–3.95)
|
1 (20)
|
0.86 (0.07–9.7)
|
2 (13.3)
|
0.58 (0.11–2.93)
|
BMI (kg/m2)
|
<25
|
151 (29.9)
|
22 (31.4)
|
1
|
2 (22.2)
|
1
|
24 (30.4)
|
1
|
0 (0)
|
1
|
3 (60)
|
1
|
3 (20)
|
1
|
25–30
|
230 (45.5)
|
27 (38.6)
|
0.8 (0.44–1.46)
|
3 (33.3)
|
0.98 (0.16–5.96)
|
30 (38.0)
|
0.82 (0.46–1.45)
|
5 (50)
| |
1 (20)
|
0.21 (0.02–2.12)
|
6 (40)
|
1.31 (0.32–5.33)
|
≥30
|
124 (24.6)
|
21 (30)
|
1.1 (0.61–2.21)
|
4 (44.4)
|
2.43 (0.43–16.51)
|
25 (31.6)
|
1.26 (0.69–2.33)
|
5 (50)
| |
1 (20)
|
0.40 (0.04–3.95)
|
6 (40)
|
2.43 (0.59–9.93)
|
FPG (mg/d)
|
<100
|
289 (56.2)
|
51 (70.8)
|
1
|
7 (77.8)
|
1
|
58 (71.6)
|
1
|
7 (77.8)
|
1
|
2 (40)
|
1
|
9 (64.3)
|
1
|
100–126
|
176 (34.2)
|
17 (23.6)
|
0.54 (0.3–0.97)*
|
1 (11.1)
|
0.23 (0.02–1.92)
|
18 (22.2)
|
0.51 (0.29–0.89)*
|
2 (22.2)
|
0.46 (0.09–2.28)
|
1 (20)
|
0.82 (0.07–9.12)
|
3 (21.4)
|
0.54 (0. 14–2.04)
|
≥126
|
49 (9.5)
|
4 (5.6)
|
0.46 (0.16–1.33)
|
1 (11.1)
|
0.84 (0.10–6.99)
|
5 (6.2)
|
0.5 (0.19–1.33)
|
0 (0)
| |
2 (40)
|
5.8 (0.81–42.85)
|
2 (14.3)
|
1.31 (0.27–6.24)
|
Smoking
|
Yes
|
42 (8.1)
|
4 (5.6)
|
0.66 (0.23–1.92)
|
1 (11.1)
|
1.42 (0.17–11.62)
|
5 (6.1)
|
0.74 (0.28–1.94)
|
1 (10)
|
1.26 (0.15–10.2)
|
0 (0)
| |
1 (6.7)
|
0.81 (0.1–6.32)
|
No
|
477 (91.9)
|
68 (94.4)
|
8 (88.9)
|
76 (93.9)
|
9 (90)
|
5 (100)
|
14 (93.3)
|
Positive family history
|
Yes
|
132 (26.4)
|
29 (40.8)
|
1.92 (1.15–3.21)*
|
2 (22.2)
|
0.79 (0.16–3.88)
|
31 (38.8)
|
1.76 (1.07–2.88)*
|
7 (77.8)
|
9.75 (2.0–47.65)*
|
2 (40)
|
1.85 (0.30–11.24)
|
9 (64.3)
|
5 (1.65–15.24)*
|
No
|
368 (73.6)
|
42 (59.2)
|
7 (77.8)
|
49 (61.3)
|
2 (22.2)
|
3 (60)
|
5 (35.7)
|
TPOAb (IU/mL)
|
Positive
|
110 (23.4)
|
27 (42.2)
|
2.39 (1.39–4.11)*
|
4 (50)
|
3.2 (0.8–13.33)
|
31 (43.1)
|
2.48 (1.46–4.14)*
|
8 (80)
|
13.12 (2.74–62.72)*
|
4 (80)
|
13.12 (1.45–118.6)*
|
12 (80)
|
13.12 (3.63–47.35)*
|
TgAb (IU/mL)
|
Positive
|
3 (9.4)
|
2 (25)
|
3.22 (0.43–23.65)
|
1 (100)
|
0
|
3 (33.3)
|
4.83 (0.77–30)
|
0 (0)
| |
0 (0)
| |
0 (0)
| |
-
BMI body mass index, FPG fasting plasma glucose, TPOAb Thyroid peroxidase antibody, as considered positive when level >75 IU/mL, TgAb thyroid globulin antibody as considered positive when level >100 IU/mL, CI confidence interval
- * P value <0.05